294 related articles for article (PubMed ID: 36467733)
1. Esophageal cancer and bacterial part of gut microbiota - A multidisciplinary point of view.
Muszyński D; Kudra A; Sobocki BK; Folwarski M; Vitale E; Filetti V; Dudzic W; Kaźmierczak-Siedlecka K; Połom K
Front Cell Infect Microbiol; 2022; 12():1057668. PubMed ID: 36467733
[TBL] [Abstract][Full Text] [Related]
2. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer.
Kawasaki M; Ikeda Y; Ikeda E; Takahashi M; Tanaka D; Nakajima Y; Arakawa S; Izumi Y; Miyake S
Cancer; 2021 Feb; 127(4):512-519. PubMed ID: 33156979
[TBL] [Abstract][Full Text] [Related]
3. Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer.
Baba Y; Hara Y; Toihata T; Kosumi K; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Komohara Y; Baba H
Esophagus; 2023 Oct; 20(4):704-712. PubMed ID: 37173453
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the oral and gastric microbiome in patients with early-stage intramucosal esophageal squamous cell carcinoma.
Chen H; Jiang X; Zhu F; Yang R; Yu X; Zhou X; Tang N
BMC Microbiol; 2024 Mar; 24(1):88. PubMed ID: 38491387
[TBL] [Abstract][Full Text] [Related]
5. Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications.
Baba Y; Iwatsuki M; Yoshida N; Watanabe M; Baba H
Ann Gastroenterol Surg; 2017 Jun; 1(2):99-104. PubMed ID: 29863142
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
8. The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy.
Asili P; Mirahmad M; Rezaei P; Mahdavi M; Larijani B; Tavangar SM
J Gastrointest Cancer; 2023 Dec; 54(4):1082-1101. PubMed ID: 36600023
[TBL] [Abstract][Full Text] [Related]
9. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma.
Lamont RJ; Fitzsimonds ZR; Wang H; Gao S
Periodontol 2000; 2022 Jun; 89(1):154-165. PubMed ID: 35244980
[TBL] [Abstract][Full Text] [Related]
10. [Does the Oral Microbiome Influence Carcinogenic Changes of the Esophagus? - A Systematic Review].
Groß RW; Schmieder E; Fetzner UK; Kleinert R; Nisi A; Saely C
Ther Umsch; 2022 Apr; 79(3-4):159-166. PubMed ID: 35440197
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride.
Kang JH; Kim DJ; Choi BK; Park JW
Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726
[TBL] [Abstract][Full Text] [Related]
12. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer.
Chattopadhyay I; Verma M; Panda M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819867354. PubMed ID: 31370775
[TBL] [Abstract][Full Text] [Related]
13. Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
Peters BA; Wu J; Pei Z; Yang L; Purdue MP; Freedman ND; Jacobs EJ; Gapstur SM; Hayes RB; Ahn J
Cancer Res; 2017 Dec; 77(23):6777-6787. PubMed ID: 29196415
[TBL] [Abstract][Full Text] [Related]
14. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer.
Liu Y; Baba Y; Ishimoto T; Iwatsuki M; Hiyoshi Y; Miyamoto Y; Yoshida N; Wu R; Baba H
J Gastroenterol; 2019 Jan; 54(1):33-41. PubMed ID: 30244399
[TBL] [Abstract][Full Text] [Related]
15. Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.
Chen C; Chen L; Lin L; Jin D; Du Y; Lyu J
Appl Microbiol Biotechnol; 2021 Jun; 105(11):4415-4425. PubMed ID: 34037843
[TBL] [Abstract][Full Text] [Related]
16. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis.
Yamamura K; Baba Y; Nakagawa S; Mima K; Miyake K; Nakamura K; Sawayama H; Kinoshita K; Ishimoto T; Iwatsuki M; Sakamoto Y; Yamashita Y; Yoshida N; Watanabe M; Baba H
Clin Cancer Res; 2016 Nov; 22(22):5574-5581. PubMed ID: 27769987
[TBL] [Abstract][Full Text] [Related]
17. Oral pathogen in the pathogenesis of colorectal cancer.
Yu TC; Zhou YL; Fang JY
J Gastroenterol Hepatol; 2022 Feb; 37(2):273-279. PubMed ID: 34837266
[TBL] [Abstract][Full Text] [Related]
18. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
19. Insights into oral microbiome and colorectal cancer - on the way of searching new perspectives.
Kudra A; Muszyński D; Sobocki BK; Atzeni A; Carbone L; Kaźmierczak-Siedlecka K; Połom K; Kalinowski L
Front Cell Infect Microbiol; 2023; 13():1159822. PubMed ID: 37124035
[TBL] [Abstract][Full Text] [Related]
20. Oral-gut microbial transmission promotes diabetic coronary heart disease.
Li Y; Liu Y; Cui J; Zhu M; Wang W; Chen K; Huang L; Liu Y
Cardiovasc Diabetol; 2024 Apr; 23(1):123. PubMed ID: 38581039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
